Fresh Checks: Neko Health

A look into the startups that recently raised capital: the rounds, the investors, and why they said yes.

· Nik Alisha Binti Nik Shazwan · Analyst

· 3 min read

What Does Neko Health Do?

Neko Health is a preventative healthcare provider that utilises radiation-free full-body scanning technology, bloodwork and real-world patient data to assess cardiovascular health, skin, body composition, and other biomarkers to catch disease risk before symptoms appear in only 60 minutes.

What Made Them Tick for Investors?

Lightspeed Venture Partners

Redefining the Starting Point of Healthcare

As technology advances, so does healthcare. Many professionals in the industry are arguing that the future of healthcare lies in preventative measures - in most cases, early intervention can often differentiate between minor treatments and major health crises. Neko Health is at the frontier of this shift, and its traction proves that the demand is real: with over 100,000 scans completed and over 350,000 customers registered or waitlisted. It’s a company that fits squarely in Lightspeed’s category-defining investment thesis.

Conviction From Numbers

Neko Health is a breakthrough player in one of the biggest industries: healthcare, reimagining preventative care with its proprietary scanning technology. It has also proven high customer demand in a competitive industry, and repeated usage with over 75% of clients rebooking their sessions. They have also outlined a believable path to international expansion, having hubs in Sweden and the UK, with its sights set on the US. Together, these factors give Lightspeed all the conviction it needs to re-invest - this is a calculated bet, not just a shot in the dark.

Founder-Market Fit

The two founders, Daniel Ek and Hjalmar Nilsonne, entered healthcare from different directions. Ek is most well-known for founding Spotify - demonstrating the ability to scale a consumer subscription platform globally, turning it into a household name. On the other hand, Nilsonne holds an engineering background and hails from a family of doctors, providing insight from a technological and clinical standpoint. Together, their partnership allows for a unique viewpoint into the world of healthcare.

O.G Venture Partners

Long-Standing Personal Relationships

Eyal Ofer of O.G Venture Partners states that the firm has “known Hjalmar, Daniel and the founding team at Neko Health for years,” signalling that the investment is a continuation of trust that has compounded over the time, rather than a cold outreach. The firm didn’t need to run fresh due diligence on Neko Health, allowing conviction to stem from the history between partners and founders - thus highlighting the importance of personal networks, and that they can matter just as much as pitch decks and metrics.

Mission Alignment Over Pure Financial Return

Neko Health’s current customer base is concentrated within wealthier circles, with their 60-minute scan currently costing £299 per session - a hefty premium most people can’t afford. Yet, Ofer positions O.G Venture Partners’ investment around a longer-term vision, citing a “deep respect for their vision to redefine health for more than just the privileged few, on a global scale.” The implication is clear: O.G is betting that the technology becomes more accessible in the future, thus allowing preventative healthcare to reach a more common audience.

Visibility by Association

O.G Venture Partners has increasingly backed consumer-facing health and wellness brands, appearing to be building a position around this niche. Neko Health fits right into this thesis - blending consumer experience and medical rigor. Co-leading investment into one of the most talked-about healthcare rounds in 2026, alongside major firms like Lightspeed Venture Partners high-profile and individual backers like Mark Zuckerberg, gives O.G valuable network and visibility effects, cementing their stance as a key-player in this space.